Matthew P. Goetz

基本信息

浏览量：4

职业迁徙

个人简介

Specialties: Breast Cancer, Pharmacogenetics, Biomarkers, early phase clinical trials

研究兴趣

论文共 805 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with Parp Inhibitors: the Mayo Clinic Experience

Nusrat Jahan,Jodi Taraba, Nicholas J Boddicker, Karthik V Giridhar, Roberto A Leon-Ferre, Amye J Tevaarwerk, Elizabeth Cathcart-Rake, Ciara C O'Sullivan,Prema P Peethambaram,Timothy J Hobday, Lida A Mina, Felipe Batalini,Pooja Advani,Kostandinos Sideras,Tufia C Haddad,Kathryn J Ruddy,Matthew P Goetz,Fergus J Couch, Siddhartha Yadav

Clinical breast cancer (2024)

引用0浏览0WOS引用

Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes

Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 9 (2024): 987-993

引用0浏览0WOS引用

Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer

Matthew P. Goetz,Erika P. Hamilton,Mario Campone,Sara A. Hurvitz,Javier Cortes,Stephen Johnston,Antonio Llombart-Cussac,Peter A. Kaufman,Masakazu Toi,Guy Jerusalem,Hillary Graham,Hong Wang,Valerie M. Jansen,Lacey M. Litchfield,Miguel Martin

CLINICAL CANCER RESEARCHno. 10 (2024): 2233-2244

引用0浏览0WOS引用

Abemaciclib Plus a Nonsteroidal Aromatase Inhibitor As Initial Therapy for HR+, HER2- Advanced Breast Cancer: Final Overall Survival Results of MONARCH 3

Matthew Goetz,Masakazu Toi,Jens Huober, Joo Hyuk Sohn,Olivier Tredan,Inhae Park,Mario Campone, Shin-Cheh Chen,Luis Manual Manso,Shani Paluch-Shimon,Orit C. Freedman,Valerie Andre,Abhijoy Saha,Gertjan van Hal,Ashwin Shahir,Hiroji Iwata, Stephen R. D. Johnston,Joyce O'Shaughnessy,Xavier Pivot,Sara Tolaney,Sara Hurvitz,Antonio Llombart

CANCER RESEARCHno. 9 (2024)

引用0浏览0WOS引用

Abstract LB334: Mechanisms of endocrine resistance to letrozole, fulvestrant, and palbociclib are associated with increased sensitivity to hexyl-cuban-1-yl biguanide inhibitors of CYP3A4 mediated epoxyeicosatrienoic acid biosynthesis

Zhijun Guo,Jianxun Lei, Allison Makovec,Swaathi Jayaraman,John R. Hawse,Carol Lange,Elizabeth Ambrose,Gunda I. Georg, Tony D'Assoro,Goetz P. Matthew,David A. Potter

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Abstract 1162: Tumor-immune microenvironment associated with obesity in triple-negative breast cancer in the Mayo Clinic cohort

Songhan Pang, Yi Liu,Yaohua Ma, Zhuo Li,Roberto A. Leon-Ferre,David Zahrieh,David W. Hillman,Judy C. Boughey,James N. Ingle,Krishna R. Kalari,Fergus J. Couch,Matthew P. Goetz,Keith L. Knutson,Saranya Chumsri,E. Aubrey Thompson

Cancer Researchno. 6_Supplement (2024): 1162-1162

引用0浏览0引用

Abstract PS06-01: Results from a Pilot Study Exploring Ctdna Detection Using a Tumor-Informed Assay in the Monarche Trial of Adjuvant Abemaciclib with Endocrine Therapy in HR+, HER2-, Node-Positive, High-Risk Early Breast Cancer

Sherene Loi,Stephen Johnston,Carlos Arteaga,Stephanie Graff,Sarat Chandarlapaty,Matthew Goetz,Christine Desmedt,Jorge Reis-Filho,Hironobu Sasano,Vanessa Rodrik-Outmezguine,Anthony Sireci, Cynthia Sandoval Rubenstein,Helen Won, Deli Liu,Lacey M. Litchfield,Nicholas Turner

Cancer Researchno. 9_Supplement (2024): PS06-01

引用0浏览0引用

A Novel Risk-Adjusted Metric to Compare Hospitals on Their Antibiotic-Prescribing at Hospital Discharge

Daniel Livorsi, Jamie Merchant,Hyunkeun Cho,Matthew Goetz,Bruce Alexander,Brice Beck, Michi Goto

Antimicrobial Stewardship & Healthcare Epidemiology (2024): s21-s21

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

教授

论文共 805 篇作者统计合作学者相似作者